Clinical Trial: A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Phase III Study of VCAP-AMP-VECP vs. Biweekly CHOP in Aggressive Adult T-cell Leukemia-lymphoma (ATLL): Japan Clinical Oncology Group Study, JCOG9801.

Brief Summary: To test the superiority of VCAP-AMP-VECP regimen over biweekly-CHOP in aggressive ATLL in terms of survival benefit.

Detailed Summary: Nothing to describe.
Sponsor: Japan Clinical Oncology Group

Current Primary Outcome: Overall survival

Original Primary Outcome: Same as current

Current Secondary Outcome:

• Toxicity
• CR rate
• Progression free survival

Original Secondary Outcome: Same as current

Information By: Japan Clinical Oncology Group

Dates:
Date Received: September 1, 2005
Date Started: August 1998
Date Completion: December 2004
Last Updated: September 20, 2016
Last Verified: September 2016